Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IPACK Block for Post-Op Analgesia in ACL Reconstruction
NCT05286307Phase 4Completed
- Sponsor
- NYU Langone Health
- Start
- Jul 2022
- Primary completion
- Mar 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of bupivacaine in postoperative pain, sponsored by NYU Langone Health. Started Jul 2022; status: completed.
02
Drugs
bupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT05286307.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05286307.